Development and Validation of a New HPLC Method for the Simultaneous Determination of Paracetamol, Ascorbic Acid, and Pseudoephedrine HCl in their Co-formulated Tablets : Application to in vitro Dissolution Testing

DOI PDF Web Site Web Site Web Site ほか1件をすべて表示 一部だけ表示 被引用文献1件 参考文献9件
  • IBRAHIM Fawzia
    Department of Analytical Chemistry, Faculty of Pharmacy, University of Mansoura
  • EL-ENANY Nahed
    Department of Analytical Chemistry, Faculty of Pharmacy, University of Mansoura
  • EL-SHAHENY Rania N.
    Department of Analytical Chemistry, Faculty of Pharmacy, University of Mansoura
  • MIKHAIL Ibraam E.
    Department of Analytical Chemistry, Faculty of Pharmacy, University of Mansoura

書誌事項

タイトル別名
  • Development and Validation of a New HPLC Method for the Simultaneous Determination of Paracetamol, Ascorbic Acid, and Pseudoephedrine HCl in their Co-formulated Tablets. Application to <i>in vitro</i> Dissolution Testing
公開日
2015
資源種別
journal article
DOI
  • 10.2116/analsci.31.943
公開者
社団法人 日本分析化学会

この論文をさがす

説明

The first HPLC method was developed for the simultaneous determination of paracetamol (PC), ascorbic acid (AA), and pseudoephedrine HCl (PE) in their co-formulated tablets. Separation was achieved on a C18 column in 5 min using a mobile phase composed of methanol-0.05 M phosphate buffer (35:65, v/v) at pH 2.5 with UV detection at 220 nm. Linear calibration curves were constructed over concentration ranges of 1.0 – 50.0, 3.0 – 60.0 and 3.0 – 80.0 μg mL−1 for PC, AA, and PE, respectively. The method was validated and applied for the simultaneous determination of these drugs in their tablets with average % recoveries of 101.17 ± 0.67, 98.34 ± 0.77, and 98.95 ± 1.11%, for PC, AA, and PE, respectively. The proposed method was also used to construct in vitro dissolution profiles of the co-formulated tablets containing the three drugs.

収録刊行物

  • Analytical Sciences

    Analytical Sciences 31 (9), 943-947, 2015

    社団法人 日本分析化学会

被引用文献 (1)*注記

もっと見る

参考文献 (9)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ